| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |